Drug Database
Back to search

Netherlands· NL-82533e9f3045

Symtuza 800 mg/150 mg/200 mg/10 mg filmomhulde tabletten

A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing cobicistat + darunavirethanolaat + emtricitabine + tenofoviralafenamidefumaraat, registered in Netherlands by Janssen-Cilag International NV. The same ATC class is registered in 12 of our 19 countries.

ATC J05AR22

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSymtuza 800 mg/150 mg/200 mg/10 mg fi…ATCJ05AR22REGISTER NO.NL-82533e9f3045PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cobicistat + darunavirethanolaat + emtricitabine + tenofoviralafenamidefumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.

Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine, tenofovir alafenamide, darunavir and cobicistat products by name

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
COBICISTAT + DARUNAVIRETHANOLAAT + EMTRICITABINE + TENOFOVIRALAFENAMIDEFUMARAAT
Manufacturer
Janssen-Cilag International NV
Country
Netherlands (NL)
ATC code
J05AR22
ATC class
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/17/1225

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J05AR22

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat, as other registers publish it.

All emtricitabine, tenofovir alafenamide, darunavir and cobicistat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a95d99ea-bdba-4f86-b242-9360a0ac503c
GET /v1/drugs/a95d99ea-bdba-4f86-b242-9360a0ac503c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/symtuza-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Emtricitabine, tenofovir alafenamide, darunavir and cobicistat",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120004",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "COBICISTAT",
    "DARUNAVIRETHANOLAAT",
    "EMTRICITABINE",
    "TENOFOVIRALAFENAMIDEFUMARAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2017/09/21",
  "procedure_number": "EMEA/H/C/004391",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1225",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console